Avaleht/Aktsiad/NXL

NXL

USD

Nexalin Technology Inc. Common Stock

$1.320-0.020 (-1.493%)

Reaalajas hind

Healthcare

Meditsiiniseadmed

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$1.340

Kõrge

$1.340

Madal

$1.310

Maht

1.75M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

24.0M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

4.35M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.702Praegune $1.320Kõrge $4.49

Seotud uudised

30. okt 2025 · 12:30

GlobeNewswire

Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel

HOUSTON, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that

Vaata rohkem

Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel

13. okt 2025 · 12:30

GlobeNewswire

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer's and Traumatic Brain Injury Programs

HOUSTON, TX, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today

Vaata rohkem

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer's and Traumatic Brain Injury Programs

10. okt 2025 · 12:00

GlobeNewswire

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

HOUSTON, TX, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is excited

Vaata rohkem